IRIS

Sfoglia per Titolo

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 34.108 a 34.127 di 46.106
Titolo Data di pubblicazione Autore(i) File
Prostate Cancer Diagnosis: Importance of Individualized Risk Stratification Models over PSA Alone 1-gen-2008 Chun, Fk; Karakiewicz, Pi; Briganti, Alberto
Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer: A validation study on an Italian patient population undergoing first and repeat biopsy 1-gen-2012 Bollito, E; De Luca, S; Cicilano, M; Passera, R; Grande, S; Maccagnano, C; Cappia, S; Milillo, A; Montorsi, Francesco; Scarpa, Rm; Papotti, M; Randone, Df
Prostate cancer imaging 1-gen-2013 Picchio, M; Piert, M.
Prostate cancer nomograms are superior to neural networks. 1-gen-2006 Karakiewicz, Pi; Chun, Fk; Briganti, Alberto; Perrotte, P; Mccormack, M; Benard, F; Valiquette, L; Graefen, M; Saad, F.
Prostate cancer nomograms: an update 1-gen-2006 Chun, Fk; Karakiewicz, P; Briganti, Alberto; Gallina, A; Kattan, Mw; Montorsi, Francesco; Huland, H; Graefen, M.
Prostate cancer recurrence: can PSA guide imaging? 1-gen-2015 Mapelli, P.; Panebianco, V.; Picchio, Maria
Prostate Cancer Registries: Current Status and Future Directions 1-gen-2016 Gandaglia, G; Bray, F; Cooperberg, Mr; Karnes, Rj; Leveridge, Mj; Moretti, K; Murphy, Dg; Penson, Df; Miller, Dc
Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases 1-gen-2020 Deantoni, Cl; Fodor, A; Cozzarini, C; Fiorino, C; Brombin, C; Di Serio, C; Calandrino, R; Di Muzio, N
Prostate cancer: from Gleason scoring to prognostic grade grouping 1-gen-2016 Montironi, Rodolfo; Santoni, Matteo; Mazzucchelli, Roberta; Burattini, Luciano; Berardi, Rossana; Galosi Andrea, B.; Cheng, Liang; Lopez Beltran, Antonio; Briganti, Alberto; Montorsi, Francesco; Scarpelli, Marina
Prostate needle biopsy: what we do and what should be improved 1-gen-2013 Fraggetta, F; Pepe, P; Improta, G; Aragona, F; Colecchia, M
Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer. 1-gen-2006 Chun, Fk; Perrotte, P; Briganti, Alberto; Benayoun, S; Lebeau, T; Ramirez, A; Lewinshtein, Dj; Valiquette, L; Guay, Jp; Karakiewicz, P. I.
Prostate volume and adverse prostate cancer features: Fact not artifact 1-gen-2007 Briganti, Alberto; Chun Felix, K. H.; Suardi, Nazareno; Gallina, Andrea; Walz, Jochen; Graefen, Markus; Shariat, Shahrokh; Ebersdobler, Andreas; Rigatti, Patrizio; Perrotte, Paul; Saad, Fred; Montorsi, Francesco; Huland, Hartwig; Karakiewicz Pierre, I.
PROSTATE VOLUME AT INITIAL BIOPSY IS THE MOST IMPORTANT PREDICTOR OF REPEAT BIOPSY OUTCOME. VALIDATION OF A NOVEL PREDICTIVE TOOL 1-gen-2006 Chun, Fkh; Briganti, Alberto; Ahyai, S; Walz, J; Scattoni, V; Salonia, Andrea; Steuber, T; Haese, A; Kim, J; Nakagami, Y; Latchemsetty, K; Bordon, L; Tachibana, M; Porter, C; Montorsi, Francesco; Ohori, M; Rigatti, P; Graefen, M; Huland, H; Karakiewicz, Pi
Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting RID F-5134-2010 1-gen-2011 Guazzoni, GIORGIO FERRUCCIO; Nava, Luciano; Lazzeri, Massimo; Scattoni, Vincenzo; Lughezzani, Giovanni; Maccagnano, Carmen; Dorigatti, Fernanda; Ceriotti, Ferruccio; Pontillo, Marina; Bini, Vittorio; Freschi, Massimo; Montorsi, Francesco; Rigatti, Patrizio
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium 1-gen-2007 Chun, Fkh; Briganti, A; Gallina, A; Hutterer, Gc; Shariat, Sf; Antebie, E; Walz, J; Roehrborn, Cg; Salonia, Andrea; Rigatti, P; Saad, F; Huland, H; Montotsi, F; Graefen, M; Karakiewicz, Pi
Prostate-specific antigen is not increased in young men by ultraendurance sport performances 1-gen-1997 Banfi, Giuseppe; M., Pontillo; A., Dolci; G. S., Roi
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 1-gen-2012 Giovacchini, Giampiero; Picchio, Maria; Parra Rita, G.; Briganti, Alberto; Gianolli, Luigi; Montorsi, F; Messa, Cristina
Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and Beyond 1-gen-2021 Gandaglia, G.; Leni, R.; Fossati, N.; Cucchiara, V.; Montorsi, F.; Briganti, A.
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 1-gen-2022 Gandaglia, Giorgio; Mazzone, Elio; Stabile, Armando; Pellegrino, Antony; Cucchiara, Vito; Barletta, Francesco; Scuderi, Simone; Robesti, Daniele; Leni, Riccardo; Samanes Gajate, Ana Maria; Picchio, Maria; Gianolli, Luigi; Brembilla, Giorgio; De Cobelli, Francesco; van Oosterom, Matthias N; van Leeuwen, Fijs W B; Montorsi, Francesco; Briganti, Alberto
Prostate-specific membrane antigen – Guided surgery 1-gen-2020 Maurer, T.; Graefen, M.; van der Poel, H.; Hamdy, F.; Briganti, A.; Eiber, M.; Wester, H. -J.; van Leeuwen, F. W. B.
Mostrati risultati da 34.108 a 34.127 di 46.106
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile